Rhode Island H7075 requires health plans to cover at least one type of glucagon medication for hypoglycemia without copayment or deductible.

Rhode Island H7075 mandates that health plans providing prescription benefits cover at least one type of glucagon auto-injector, nasal spray, or non-reconstituted formulation to treat hypoglycemia. The coverage will be available without copayment or deductible, starting from January 1, 2027. Health plans paired with federally qualified health savings accounts may apply a deductible. The bill aims to ensure the availability of life-saving medications for diabetes management.

Rhode Island H7075 requires health plans to cover at least one type of glucagon medication for hypoglycemia without copayment or deductible.

Rhode Island H7075 mandates that health plans providing prescription benefits cover at least one type of glucagon auto-injector, nasal spray, or non-reconstituted formulation to treat hypoglycemia. The coverage will be available without copayment or deductible, starting from January 1, 2027. Health plans paired with federally qualified health savings accounts may apply a deductible. The bill aims to ensure the availability of life-saving medications for diabetes management.